Court Approval

Surgical Innovations Group plc

("SI" or "the Group")

 Court Approval

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, is pleased to announce that on 15 July 2010, the Court approved its application for the cancellation of its share premium account through the offsetting of accumulated losses.

- Ends -

For further information:

Media enquiries:

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.

The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards. Through an established network of distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia.

Surgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen. The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue stream and delivering the optimum procedure performance to cost ratio. The Group's products include:

In addition to its own branded instruments, the Group also designs and manufactures devices on an OEM basis for large medical device companies including Teleflex Medical, Gyrus, Olympus and CareFusion.

For more information, see www.surginno.com